Hydrophobic acrylic IOL corrects corneal astigmatism

Article

A new hydrophobic acrylic IOL is an effective, safe and predictable method for the correction of corneal astigmatism in patients undergoing routine cataract surgery.

A new hydrophobic acrylic IOL is an effective, safe and predictable method for the correction of corneal astigmatism in patients undergoing routine cataract surgery, according to recently published data.

Dr Amy L. Sheppard et al., School of Life and Health Sciences, Aston University, Birmingham, UK, completed a cohort study in four hospital eye clinics in Europe on 67 eyes of 60 patients.

The outcome measures included uncorrected distance visual acuity (UDVA), corrected distance visual acuity, manifest refraction and keratometry. The team also documented individual patient satisfaction with uncorrected vision and the surgeon’s evaluation of ease of handling and performance of the IOL.

Four to eight weeks after cataract surgery, the mean UDVA was 0.15 logMAR ± 0.17 and UDVA was 20/40 or better in 88% of eyes. Mean refractive cylinder decreased significantly postoperatively from −1.91 ± 1.07 D to −0.67 ± 0.54 D. However, there was no change in keratometric cylinder. The good UDVA resulted in high levels of patient satisfaction.

The abstract for this study has been published in the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.